Sign in
AEZS Stock Price, Chart, Stats & News
Aeterna Zentaris Inc.
Save
Aeterna Zentaris Inc. (AEZS) does not currently pay a dividend.
25.38M
Market cap
–
Current P/E
–
Forward P/E
AEZS chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Aeterna Zentaris Inc., established in 1990 and based in Summerville, South Carolina, is a specialized biopharmaceutical company focused on innovating and commercializing therapeutic drugs and diagnostic tests. Its flagship product is Macrilen, scientifically known as macimorelin. This orally administered peptidomimetic ghrelin receptor (GHSR-1a) agonist functions by activating the GHSR-1a receptor, thereby stimulating the secretion of growth hormone.
Similar securities
Based on sector and market capitalization
Report issue